DUBLIN, July 29, 2021--(BUSINESS WIRE)--The "Biochips Market Report: Trends, Forecast, and Competitive Analysis" report has been added to ResearchAndMarkets.com's offering.
The future of the biochip market looks promising with opportunities in the hospitals, diagnostics centers, academic and research institutes, biotechnology and pharmaceutical industries. The global biochip market is expected to grow with a CAGR of 18% from 2019 to 2024. The major growth drivers for this market are increasing adoption of personalized medicine, increase in prevalence of cancer, immunological disorders, viral infections, geriatric population, and growing applications of biochip.
A report of more than 150-pages is developed to help in your business decisions. To learn the scope of, benefits, companies researched and other details of the biochip market, then read this report.
The study includes the biochip market size and forecast for the global biochip market through 2024, segmented by chip type, fabrication technology, application, material, end use, and region.
Some of the biochips companies profiled in this report include Abbott Laboratories, Agilent Technologies, Perkinelmer, Fluidigm, Illumina, GE Healthcare, Bio-Rad Laboratories, Cepheid, Thermo Fisher Scientific, and F. Hoffmann-La Roche.
Some of the features of 'Global Biochip market 2019-2024: Trends, Forecast, and Opportunity Analysis' include
Market size estimates: Global biochips market size estimation in terms of value ($M) shipment.
Trend and forecast analysis: Market trend (2013-2018) and forecast (2019-2024) by segments and region.
Segmentation analysis: Global market size by various applications such as by chip type, fabrication technology, application, material, end use, and region.
Regional analysis: Global biochips market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
Growth opportunities: Analysis on growth opportunities in different applications and regions for biochips in the global biochip market.
Strategic analysis: This includes M&A, new product development, and competitive landscape for, biochips in the global biochip market.
Analysis of competitive intensity of the industry based on Porter's Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the global biochip market by chip type (DNA chips, lab-on-a-chips, protein chips and others), fabrication technology (microarrays and microfluidics), application(drug discovery and development, disease diagnostics, genomics, proteomics, agriculture and others), material (glass, polymers, silicon and others), end use (biotechnology and pharmaceutical industries, hospitals and diagnostics centers, academic and research institutes, and others), and region (North America, Europe, Asia-Pacific, Rest of the World (ROW))?
Q.2.Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the biochip market?
Q.5. What are the business risks and threats to the biochip market?
Q.6. What are emerging trends in this biochip market and the reasons behind them?
Q.7. What are some changing demands of customers in the biochip market?
Q.8. What are the new developments in the biochip market? Which companies are leading these developments?
Q.9. Who are the major players in this biochip market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this biochip area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in biochip market?
Key Topics Covered:
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2013 to 2024
3.1: Macroeconomic Trends and Forecast
3.2: Global Biochips Market: Trends and Forecast
3.3: Global Biochips Market by Chip Type
3.3.1: DNA Chips
3.3.3: Protein Chips
3.4: Global Biochips Market by Fabrication Technology
3.5: Global Biochips Market by Application
3.5.1: Drug Discovery and Development
3.5.2: Disease Diagnostics
3.6: Global Biochips Market by Material
3.7: Global Biochips Market by End Use
3.7.1: Biotechnology and Pharmaceutical Industries
3.7.2: Hospitals and Diagnostics Centers
3.7.3: Academic and Research Institutes
4. Market Trends and Forecast Analysis by Region
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter's Five Forces Analysis.
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.2: Emerging Trends in Global Biochips Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of Global Biochips Market
6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Market
7. Company Profiles of Leading Players
For more information about this report visit https://www.researchandmarkets.com/r/peayi8
View source version on businesswire.com: https://www.businesswire.com/news/home/20210729005498/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900